Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chitosan + mineral trioxide aggregate
- Development stage
- Unknown
- Lead developer
- Nourhan M. Aly
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
This combination therapy consists of a 3D porous chitosan scaffold and Mineral Trioxide Aggregate (MTA), specifically the fast-setting EndoCem Zr formulation. It is designed for use as a pulpotomy agent in mature permanent teeth affected by irreversible pulpitis. Chitosan, a biocompatible and biodegradable polysaccharide derived from chitin, serves as a scaffold to support cellular attachment and tissue regeneration within the pulp chamber. MTA is a bioactive bioceramic material that releases calcium ions and creates an alkaline environment, promoting the formation of a mineralized dentinal bridge and providing a bacterial-tight seal. The combination aims to maintain tooth vitality and promote pulp healing as an alternative to conventional root canal treatment.
- Brand names
- EndoCem Zr
- Other names
- Chitosan scaffold/ MTA pulp dressing materialChitosan + MTAChitosan scaffold and Mineral trioxide aggregate
02
Targets
TGFB1 (Transforming growth factor Beta-1 proprotein)BMP2 (Bone morphogenetic protein 2)
Beyond the preview
Go deeper on chitosan + mineral trioxide aggregate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chitosan + mineral trioxide aggregate.